Talphera, Inc.
TLPH • NASDAQ
Talphera, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Vincent J. Angotti, with a market cap of $37.1M.
CEOVincent J. Angotti
Next Earnings
Upcoming earnings announcement for Talphera, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.08
Earnings History
Past 12 earnings reports for Talphera, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Q4 2025 | -$0.06Est: -$0.07 | +14.3% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.11Est: -$0.12 | +8.3% | $1.0K | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.10Est: -$0.12 | +16.7% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.10Est: -$0.14 | +28.6% | $27.0K | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.07Est: -$0.16 | +56.3% | - | — | 10-K/A |
| Nov 13, 2024 | Q3 2024 | -$0.13Est: -$0.20 | +35.0% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.15Est: -$0.23 | +34.8% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.16Est: -$0.22 | +27.3% | - | — | 10-Q |
| Mar 6, 2024 | Q4 2023 | -$0.25Est: -$0.20 | -25.0% | $281.0KEst: $280.0K | +0.4% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.08Est: -$0.28 | +71.4% | $117.0KEst: $130.0K | -10.0% | — |
| Aug 10, 2023 | Q2 2023 | -$0.40Est: -$0.53 | +24.5% | $253.0KEst: $70.0K | +261.4% | — |
| May 10, 2023 | Q1 2023 | -$0.75Est: -$0.78 | +3.8% | - | — | — |